InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（6 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
6
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Lurker Nancy, 董事长兼首席执行官. Director active across 4 companies, notably EyePoint Pharmaceuticals, Inc.. In total, 29 filings have been published. Breakdown: 1 buy · 6 sells. Total volume traded: €957k. History available since 14 June 2021. The latest transaction was disclosed on 21 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Lurker Nancy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报29 总计
6,142 股Ordinary SharesSEC:0001520262-26-000089:0
1,475 股@ US$36.950.0010% mcap100.0% 占其流量Ordinary SharesSEC:0001520262-26-000089:1
4,500 股@ US$35.96910.0094% mcap50.0% 占其流量Common StockSEC:0001450485-26-000007:0
3,751 股Ordinary SharesSEC:0001520262-26-000070:0
901 股@ US$33.360.0003% mcap35.4% 占其流量Ordinary SharesSEC:0001520262-26-000070:1
75,133 股0Common StockSEC:0001450485-26-000005:0
12,666 股0Common StockSEC:0001450485-26-000003:0
9,300 股@ US$15.105114.7% 占其流量Common StockSEC:0001450485-25-000009:0
200 股@ US$14.950.4% 占其流量Common StockSEC:0001450485-25-000007:0
11,111 股0Common StockSEC:0001562180-25-005390:0
8,013 股Ordinary SharesSEC:0001127602-25-016202:0
9,791 股0Common StockSEC:0001062993-25-009809:0
2,323 股Ordinary SharesSEC:0001127602-25-012018:0
20,000 股0Common StockSEC:0001562180-25-001134:0
12,726 股0Common StockSEC:0001062993-25-001754:0
12,667 股0Common StockSEC:0001562180-25-000228:0
3,173 股@ US$7.882.6% 占其流量Common StockSEC:0001562180-24-006378:0
标准退出：2024年11月14日 (T+90)
11,111 股0Common StockSEC:0001562180-24-005700:0
20,000 股0Common StockSEC:0001562180-24-001294:0
5,044 股@ US$24.970213.3% 占其流量Common StockSEC:0001562180-24-000636:0
75,133 股0Common StockSEC:0001562180-24-000402:0
52,208 股0Common StockSEC:0001562180-24-000133:0
20,000 股@ US$20.7643.7% 占其流量Common StockSEC:0001562180-23-008170:0
17,533 股0Common StockSEC:0001562180-23-001330:0
12,466 股0Common StockSEC:0001562180-22-002135:0
29 条申报中的 25 条
About Lurker Nancy
Lurker Nancy is Président-Directeur Général. She has 29 filings in total, and across the recent sample of 29 filings, the reported buy amount is EUR 22787 and the reported sell amount is EUR 934332, with a date range from 2021-06-15 to 2026-05-22. The modal transaction nature is Levée d'options; among the recent filings are transactions involving EyePoint Pharmaceuticals, Inc., COLLEGIUM PHARMACEUTICAL, INC and Alkermes plc.
